All About Myeloproliferative Disease & Support
This online portal provides information for patients and their families about myeloproliferative neoplasms (MPN), or myeloproliferative disorders (MPD). MPN is a group of blood disorders characterized by an overproduction of one or more types of blood cells: red blood cells, white blood cells, and/or platelets. As a rule, MPNs develop slowly, and different blood cells are affected in different MPNs. Many patients with chronic myeloproliferative disease (code D47.1), with proper medical supervision and treatment, may have no clinical manifestations, or they may be minimal for a long time.
There are several forms of myeloproliferative disorder icd 10, three of which are traditionally grouped together because of their common features. These three diseases are often referred to as “classic”, “chimeric BCR-ABL negative”, and “Philadelphia negative”. These are the following diseases:
- Polycythemia vera (PV)
- Essential thrombocythemia (ET)
- Myelofibrosis (MF)
These three forms of myeloproliferative disorders are rare diseases. In the United States, there are approximately 148,000 people with polycythemia vera, about 134,000 people with essential thrombocythemia, and about 13,000 people with myelofibrosis.
This informative portal focuses on myeloproliferative disorder signs, diagnosis, and treatment. In addition, it provides information on how to get support and help for people living with myeloproliferative disorders.
Watch the video below to get a better idea of myeloproliferative neoplasms:
Myeloproliferative Neoplasms – Cancer Care
Our online portal provides free information to patients with blood cancer and their families. Below we list various helpful resources available to you. This information will help you learn more about myeloproliferative disease, formulate your questions for doctors, and get professional medical help and support.
For Myeloproliferative Neoplasms
CancerCare Co-Payment Assistance Foundation
DKMS We Delete Blood Cancer
Patient Access Network (PAN) Foundation
The Leukemia & Lymphoma Society (LLS)